139 related articles for article (PubMed ID: 9865957)
1. Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct.
Chen GQ; Sun Y; Jin R; Gouaux E
Protein Sci; 1998 Dec; 7(12):2623-30. PubMed ID: 9865957
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.
Mayer ML; Olson R; Gouaux E
J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533
[TBL] [Abstract][Full Text] [Related]
3. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
Valentine ER; Palmer AG
Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
[TBL] [Abstract][Full Text] [Related]
4. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
[TBL] [Abstract][Full Text] [Related]
5. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
6. Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor.
Armstrong N; Jasti J; Beich-Frandsen M; Gouaux E
Cell; 2006 Oct; 127(1):85-97. PubMed ID: 17018279
[TBL] [Abstract][Full Text] [Related]
7. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain.
Speranskiy K; Kurnikova M
Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887
[TBL] [Abstract][Full Text] [Related]
8. A molecular envelope of the ligand-binding domain of a glutamate receptor in the presence and absence of agonist.
Abele R; Svergun D; Keinänen K; Koch MH; Madden DR
Biochemistry; 1999 Aug; 38(34):10949-57. PubMed ID: 10460150
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.
Naur P; Vestergaard B; Skov LK; Egebjerg J; Gajhede M; Kastrup JS
FEBS Lett; 2005 Feb; 579(5):1154-60. PubMed ID: 15710405
[TBL] [Abstract][Full Text] [Related]
10. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of agonist recognition by the ligand-binding core of the ionotropic glutamate receptor 4.
Kasper C; Frydenvang K; Naur P; Gajhede M; Pickering DS; Kastrup JS
FEBS Lett; 2008 Dec; 582(29):4089-94. PubMed ID: 19022251
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
Laube B; Schemm R; Betz H
Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
[TBL] [Abstract][Full Text] [Related]
13. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
Jin R; Gouaux E
Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations for glutamate-binding and cleft-closing processes of the ligand-binding domain of GluR2.
Okada O; Odai K; Sugimoto T; Ito E
Biophys Chem; 2012 Mar; 162():35-44. PubMed ID: 22284903
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of a glutamate receptor (GluR2) ligand binding domain in Escherichia coli: application of a novel protein folding screen.
Chen GQ; Gouaux E
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13431-6. PubMed ID: 9391042
[TBL] [Abstract][Full Text] [Related]
17. The structure of a mixed GluR2 ligand-binding core dimer in complex with (S)-glutamate and the antagonist (S)-NS1209.
Kasper C; Pickering DS; Mirza O; Olsen L; Kristensen AS; Greenwood JR; Liljefors T; Schousboe A; Wätjen F; Gajhede M; Sigurskjold BW; Kastrup JS
J Mol Biol; 2006 Apr; 357(4):1184-201. PubMed ID: 16483599
[TBL] [Abstract][Full Text] [Related]
18. Identification of linker regions and domain borders of the transcription activator protein NtrC from Escherichia coli by limited proteolysis, in-gel digestion, and mass spectrometry.
Bantscheff M; Weiss V; Glocker MO
Biochemistry; 1999 Aug; 38(34):11012-20. PubMed ID: 10460156
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal domain of alphaB-crystallin is protected from proteolysis by bound substrate.
Aquilina JA; Watt SJ
Biochem Biophys Res Commun; 2007 Feb; 353(4):1115-20. PubMed ID: 17207466
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and preliminary crystallographic characterization of the vitamin D sterol- and actin-binding by human vitamin D-binding protein.
Swamy N; Head JF; Weitz D; Ray R
Arch Biochem Biophys; 2002 Jun; 402(1):14-23. PubMed ID: 12051678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
